We are a firm built upon strong focus on the patient at the center of everything that we do. Apexian has a dynamic culture, which supports our commitment to patients. We are committed to developing strong relationships with a variety of experienced individuals, academic institutions, contract research organizations and regulatory agencies to bring innovative products to market. From the beginning as our founder, Mark Kelley, PhD, worked to identify potential molecules that would impact the APE1/Ref-1 biology, we have sought to develop relationships that are built upon mutual respect and aimed at addressing some of the most difficult cancers that still cut lives short in our world.
We are absolutely driven to move ideas toward the clinic so that concepts can be tested where they will really make a difference in the lives of people.
Apexians have world class experience in their individual fields with a track record that provides insights to develop transformational product to patients. We pride ourselves on a environment of teamwork that encourages scientific collaboration and unlimited possibilities. Our exceptional employees will not stop until we overcome some of the most difficult diseases known to man and make a difference in the length and quality of life for cancer patients. We have found that as long as we focus on delivering for patients everyone along the process catches the passion as well. As a result, working together we can achieve extraordinary things. Our values are embodied in “better is always possible” to help patients. We believe our scientific capabilities and our values set us apart from other companies.